Cargando…
The lncRNAs RP1-261G23.7, RP11-69E11.4 and SATB2-AS1 are a novel clinical signature for predicting recurrent osteosarcoma
Background: Osteosarcoma is the most common primary bone malignancy in children and adolescents. In order to find factors related to its recurrence, and thus improve recovery prospects, a powerful clinical signature is needed. Long noncoding RNAs (lncRNAs) are essential in osteosarcoma processes and...
Autores principales: | Ying, Tang, Dong, Jin-ling, Yuan, Cen, Li, Peng, Guo, Qingshan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6944665/ https://www.ncbi.nlm.nih.gov/pubmed/31850493 http://dx.doi.org/10.1042/BSR20191251 |
Ejemplares similares
-
Novel compound heterozygous EYS variants may be associated with arRP in a large Chinese pedigree
por: Wei, Chunli, et al.
Publicado: (2020) -
BCL11A: a potential diagnostic biomarker and therapeutic target in human diseases
por: Yin, Jiawei, et al.
Publicado: (2019) -
LncRNA RP11-248E9.5 and RP11-456D7.1 are Valuable for the Diagnosis of Childhood Pneumonia
por: Chen, Xiudong, et al.
Publicado: (2021) -
Long non‐coding RNA RP11‐552M11.4 promotes cells proliferation, migration and invasion by targeting BRCA2 in ovarian cancer
por: Huang, Kejin, et al.
Publicado: (2018) -
Detection methods for influenza A H1N1 virus with special reference to biosensors: a review
por: Ravina,, et al.
Publicado: (2020)